Rong Yang
Direttore/Membro del Consiglio presso NATURE'S SUNSHINE PRODUCTS, INC.
Patrimonio netto: 432 076 $ in data 30/04/2024
Profilo
Rong Yang is currently the Chief Executive Officer at Fosun Pharma USA, Inc. and an Independent Director at Nature's Sunshine Products, Inc. Yang holds a Master's in Business Administration from Harvard University, an undergraduate degree from Beijing Foreign Studies University, and a graduate degree from Nankai University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
06/05/2024 | 22 249 ( 0.12% ) | 432 076 $ | 30/04/2024 |
Posizioni attive di Rong Yang
Società | Posizione | Inizio |
---|---|---|
NATURE'S SUNSHINE PRODUCTS, INC. | Direttore/Membro del Consiglio | 01/06/2022 |
Fosun Pharma USA, Inc.
Fosun Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Fosun Pharma USA, Inc. is a fast-growing pharmaceutical company that was founded in 2017. The private company is based in Princeton, NJ. The company, which is a subsidiary of Fosun Pharma, continually works to enhance its existing portfolio of specialty pharmaceutical injectables and to build its pipeline with both innovative and generic pharmaceutical drugs. Fosun Pharma USA is dedicated to bringing products to market to improve patient access to medicine and innovation. Rong Yang has been the CEO of the company since 2022. | Amministratore Delegato | 01/01/2022 |
Formazione di Rong Yang
Beijing Foreign Studies University | Undergraduate Degree |
Nankai University | Graduate Degree |
Harvard University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
NATURE'S SUNSHINE PRODUCTS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Fosun Pharma USA, Inc.
Fosun Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Fosun Pharma USA, Inc. is a fast-growing pharmaceutical company that was founded in 2017. The private company is based in Princeton, NJ. The company, which is a subsidiary of Fosun Pharma, continually works to enhance its existing portfolio of specialty pharmaceutical injectables and to build its pipeline with both innovative and generic pharmaceutical drugs. Fosun Pharma USA is dedicated to bringing products to market to improve patient access to medicine and innovation. Rong Yang has been the CEO of the company since 2022. | Health Technology |
- Borsa valori
- Insiders
- Rong Yang